ARFGEF3 and breast carcinoma: Knocking down BIG3 drastically reduces the growth of multiple breast cancer cell lines, and immunohistochemical staining of ERα-positive breast cancer clinical specimens has revealed BIG3 positivity in ~90% of cases [88, 89].